Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vermeire

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
Gut|December 20, 2005
Phenotype at diagnosis predicts recurrence rates in Crohn's diseaseF L Wolters, M G Russel, J Sijbrandij, et al.
Gut|August 25, 2009
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitisI Arijs, K Li, G Toedter, et al.
Acta Gastro-Enterologica Belgica|February 14, 2013
Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn's diseaseE De Greef, I Hoffman, G D'Haens, et al.
Alimentary Pharmacology & Therapeutics|November 10, 2015
Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammationA J F Coimbra, J Rimola, S O'Byrne, et al.
Journal of Crohn'S & Colitis|May 14, 2013
Profile of pediatric Crohn's disease in BelgiumE De Greef, J M Mahachie John, I Hoffman, et al.
Genes and Immunity|June 1, 2007
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseasesP L De Jager, D Franchimont, A Waliszewska, et al.
Journal of Medical Genetics|August 19, 2007
Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohortsB L Browning, V Annese, M L Barclay, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Gut|December 20, 2005
Phenotype at diagnosis predicts recurrence rates in Crohn's diseaseF L Wolters, M G Russel, J Sijbrandij, et al.
Gut|August 25, 2009
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitisI Arijs, K Li, G Toedter, et al.
Acta Gastro-Enterologica Belgica|February 14, 2013
Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn's diseaseE De Greef, I Hoffman, G D'Haens, et al.
Alimentary Pharmacology & Therapeutics|November 10, 2015
Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammationA J F Coimbra, J Rimola, S O'Byrne, et al.
Journal of Crohn'S & Colitis|May 14, 2013
Profile of pediatric Crohn's disease in BelgiumE De Greef, J M Mahachie John, I Hoffman, et al.
Genes and Immunity|June 1, 2007
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseasesP L De Jager, D Franchimont, A Waliszewska, et al.
Journal of Medical Genetics|August 19, 2007
Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohortsB L Browning, V Annese, M L Barclay, et al.
Pageof 14